Proxy Votes Now

Home › Funds › Jackson National › JNL/Invesco Small Cap Growth Fund

JNL/Invesco Small Cap Growth Fund proxy voting record 2025-2026

Fund family: Jackson National · Filed by JNL SERIES TRUST (CIK 933691) · SEC series S000001743

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 774 with, 5 against, 5 abstentions (not counted as with management). Shareholder proposals: 1 FOR, 4 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Jackson National as a whole

The same two figures as Jackson National’s manager page (239,981 ballot items across 107 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsJackson NationalItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)95.0%75492.4%203,335
Backed environmental and social shareholder proposals at US companiesn/a02.8%2,611

Where this fund voted differently from most Jackson National funds

Each ballot item this fund voted is set against the votes of the other Jackson National funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Jackson National funds on 55 items (8.7% of the 634 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Jackson National fundsMgmtResult
IONIS PHARMACEUTICALS, INC.2026-06-04To make an advisory vote on executive compensation.AgainstFOR — 10 of 10 Jackson National fundsAgainstApproved, 96.4% support
SPX TECHNOLOGIES, INC.2026-05-12Approval of Named Executive Officers' Compensation, on a Non-binding Advisory Basis.AgainstFOR — 9 of 9 Jackson National fundsAgainstApproved, 94.1% support
TALEN ENERGY CORPORATION2026-05-05To approve, on an advisory basis, the compensation of our named executive officers.AgainstFOR — 8 of 8 Jackson National fundsAgainstApproved, 96.7% support
APPLIED INDUSTRIAL TECHNOLOGIES, INC.2025-10-21Election of Directors: Joe A. RaverWithholdFOR — 8 of 8 Jackson National fundsAgainstPassed (calculated), 89.0% support
PROTAGONIST THERAPEUTICS, INC.2026-06-17DIRECTOR: L.T. Williams, MD, PhDForABSTAIN — 7 of 7 Jackson National fundsFor—
PROTAGONIST THERAPEUTICS, INC.2026-06-17To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.AgainstFOR — 7 of 7 Jackson National fundsAgainstApproved, 94.4% support
CYTOKINETICS, INCORPORATED2026-05-27To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.AgainstFOR — 7 of 7 Jackson National fundsAgainstApproved, 97.2% support
FABRINET2025-12-11DIRECTOR: Dr. Homa BahramiAbstainFOR — 6 of 6 Jackson National fundsAgainst—
ESCO TECHNOLOGIES INC.2026-01-30Election of Directors: Robert J. PhillippyWithholdFOR — 6 of 6 Jackson National fundsAgainstElected, 87.4% support
CASELLA WASTE SYSTEMS, INC.2026-06-04To elect the following nominees as Class II directors of the Company to serve until the 2029 Annual Meeting of Stockholders: Emily Nagle GreenForWITHHOLD — 6 of 6 Jackson National fundsForElected, 66.5% support
CAVCO INDUSTRIES, INC.2025-07-29Election of Directors David A. GreenblattAgainstFOR — 6 of 6 Jackson National fundsAgainst—
BOOT BARN HOLDINGS, INC.2025-08-27Election of Directors: Lisa G. LaubeWithholdFOR — 6 of 6 Jackson National fundsAgainstElected, 78.3% support
TRANSMEDICS GROUP, INC.2026-05-20To approve an amendment to the TransMedics Group, Inc. Amended and Restated 2019 Stock Incentive Plan to increase the maximum aggregate number of shares of common stock that may be issued pursuant to awards granted under the TransMedics Group, Inc. Amended and Restated 2019 Stock Incentive Plan by 2ForAGAINST — 6 of 6 Jackson National fundsFor—
TRANSMEDICS GROUP, INC.2026-05-20To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers.AgainstFOR — 6 of 6 Jackson National fundsAgainstApproved, 95.2% support
BLOOM ENERGY CORPORATION2026-05-21DIRECTOR: Barbara BurgerForABSTAIN — 5 of 5 Jackson National fundsFor—
BLOOM ENERGY CORPORATION2026-05-21DIRECTOR: Eddy ZervigonForABSTAIN — 5 of 5 Jackson National fundsFor—
BRIDGEBIO PHARMA, INC.2026-06-22To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.AgainstFOR — 5 of 5 Jackson National fundsAgainstApproved, 95.7% support
GLAUKOS CORPORATION2026-05-28DIRECTOR: Denice M. TorresForABSTAIN — 5 of 5 Jackson National fundsFor—
RED ROCK RESORTS, INC.2026-06-04DIRECTOR: James E. Nave, D.V.M.ForABSTAIN — 5 of 5 Jackson National fundsFor—
RED ROCK RESORTS, INC.2026-06-04DIRECTOR: Robert A. Cashell, Jr.ForABSTAIN — 5 of 5 Jackson National fundsFor—
RED ROCK RESORTS, INC.2026-06-04DIRECTOR: Robert E. LewisForABSTAIN — 5 of 5 Jackson National fundsFor—
CARPENTER TECHNOLOGY CORPORATION2025-10-07DIRECTOR: Stephen M. Ward, Jr.AbstainFOR — 8 of 9 Jackson National fundsAgainst—
CAVA GROUP INC2026-06-22Election of Class III Directors James D. WhiteForWITHHOLD — 7 of 8 Jackson National fundsFor—
STEPSTONE GROUP INC2025-09-09To elect the nine director nominees named in the proxy statement, each to serve for a one-year term and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, removal, retirement or disqualification. Scott W. HartWithholdFOR — 4 of 4 Jackson National fundsAgainst—
CARGURUS, INC.2026-06-03DIRECTOR: Langley SteinertForABSTAIN — 4 of 4 Jackson National fundsFor—
Show all 55
Items 26 to 55.
CompanyMeetingItemThis fundMost Jackson National fundsMgmtResult
CARGURUS, INC.2026-06-03DIRECTOR: Manik GuptaForABSTAIN — 4 of 4 Jackson National fundsFor—
CARGURUS, INC.2026-06-03To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers for 2025.ForAGAINST — 4 of 4 Jackson National fundsFor—
BIOLIFE SOLUTIONS, INC.2025-08-20DIRECTOR: Joydeep GoswamiForABSTAIN — 4 of 4 Jackson National fundsFor—
PROTAGONIST THERAPEUTICS, INC.2026-06-17DIRECTOR: Dinesh V. Patel, Ph.D.ForABSTAIN — 6 of 7 Jackson National fundsFor—
PROTAGONIST THERAPEUTICS, INC.2026-06-17To approve the adoption of the Company's 2026 Equity Incentive Plan.ForAGAINST — 6 of 7 Jackson National fundsForApproved, 84.4% support
API GROUP CORPORATION2026-05-15To elect nine directors for a one-year term expiring at the 2027 Annual Meeting of Shareholders: Cyrus D. WalkerForAGAINST — 7 of 9 Jackson National fundsForPassed (calculated), 81.1% support
WYNDHAM HOTELS & RESORTS, INC.2026-05-14Shareholder To vote on a stockholder proposal, if properly presented at the meeting, regarding stockholder ability to act by written consent.AgainstFOR — 7 of 9 Jackson National fundsForPassed (calculated), 62.9% support
KARMAN HOLDINGS INC.2026-04-29DIRECTOR: Stephen TwittyForABSTAIN — 3 of 3 Jackson National fundsFor—
RBC BEARINGS INCORPORATED2025-09-04Election of Directors Edward D. StewartAgainstFOR — 6 of 8 Jackson National fundsAgainst—
ZURN ELKAY WATER SOLUTIONS CORPORATION2026-04-30Advisory vote to approve the compensation of Zurn Elkay's named executive officers, as disclosed in "Compensation Discussion and Analysis" and "Executive Compensation" in the Proxy Statement.AgainstFOR — 6 of 8 Jackson National fundsAgainstPassed (calculated), 87.6% support
PERMIAN RESOURCES CORPORATION2026-05-19To approve the First Amendment to the Permian Resources Corporation 2023 Long Term Incentive Plan.ForAGAINST — 8 of 12 Jackson National fundsForPassed (calculated), 71.8% support
STEPSTONE GROUP INC2025-09-09To elect the nine director nominees named in the proxy statement, each to serve for a one-year term and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, removal, retirement or disqualification. Monte M. BremWithholdFOR — 4 of 5 Jackson National fundsAgainst—
BRIGHTSPRING HEALTH SERVICES, INC.2026-05-21Election of Class II directors Steve MillerWithholdFOR — 5 of 7 Jackson National fundsAgainst—
MUELLER INDUSTRIES, INC.2026-05-07DIRECTOR: Elizabeth DonovanForABSTAIN — 6 of 9 Jackson National fundsFor—
CLEAN HARBORS, INC.2026-05-20To approve on a non-binding, advisory basis, the compensation of the Company's named executive officers as described in the Company's definitive proxy statement.ForAGAINST — 5 of 8 Jackson National fundsForPassed (calculated), 94.6% support
RBC BEARINGS INCORPORATED2025-09-04Election of Directors Barry C. BoyanForAGAINST — 5 of 8 Jackson National fundsFor—
RBC BEARINGS INCORPORATED2025-09-04Election of Directors Daniel A. BergeronForAGAINST — 5 of 8 Jackson National fundsFor—
EVERCORE INC.2026-06-10Approval of the Fourth Amended and Restated 2016 Evercore Inc. Stock Incentive Plan.AgainstFOR — 5 of 8 Jackson National fundsAgainstApproved, 68.0% support
EVERCORE INC.2026-06-10Election of Directors. Roger C. AltmanForAGAINST — 5 of 8 Jackson National fundsFor—
EVERCORE INC.2026-06-10To approve, on an advisory basis, the executive compensation of our Named Executive Officers.ForAGAINST — 5 of 8 Jackson National fundsForApproved, 94.2% support
HAMILTON LANE INCORPORATED2025-09-04Advisory, non-binding vote to approve named executive officer compensation.AgainstFOR — 5 of 8 Jackson National fundsAgainstApproved, 76.2% support
OSI SYSTEMS, INC.2025-12-11Election of Directors William F. BallhausAgainstFOR — 5 of 8 Jackson National fundsAgainst—
GUARDANT HEALTH, INC.2026-06-17Election of Class II Directors Ian ClarkForWITHHOLD — 3 of 4 Jackson National fundsFor—
GUARDANT HEALTH, INC.2026-06-17Election of Class II Directors Manuel Hidalgo MedinaForWITHHOLD — 3 of 4 Jackson National fundsFor—
BRIDGEBIO PHARMA, INC.2026-06-22DIRECTOR: Hannah A. Valantine, MDForABSTAIN — 3 of 4 Jackson National fundsFor—
PIPER SANDLER COMPANIES2026-05-20Election of Directors Jonathan J. DoyleForAGAINST — 4 of 6 Jackson National fundsFor—
COGNEX CORPORATION2026-04-29To approve, on an advisory basis, the compensation of Cognex's named executive officers, as described in the proxy statement including the Compensation Discussion and Analysis, compensation tables and narrative discussion ("say-on-pay").AgainstFOR — 4 of 7 Jackson National fundsAgainstApproved, 78.7% support
TRAVEL + LEISURE CO.2026-05-20DIRECTOR: George HerreraForABSTAIN — 4 of 7 Jackson National fundsFor—
GUARDANT HEALTH, INC.2026-06-17Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation.AgainstFOR — 3 of 5 Jackson National fundsAgainstNot approved, 90.8% support
ROCKET LAB CORPORATION2025-08-27DIRECTOR: Jon OlsonForABSTAIN — 2 of 3 Jackson National fundsFor—

Download all 55 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 88.5% of this fund’s 784 such votes could be given a sector; the other 90 (11.5%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Industrials19031.6%
Technology11110.9%
Consumer Discretionary10910.9%
Health Care10500.0%
Finance7700.0%
Energy3100.0%
Utilities2600.0%
Consumer Staples1200.0%
Real Estate1200.0%
Miscellaneous1100.0%
Telecommunications600.0%
Basic Materials400.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections5260
Audit-related1010
Say-on-Pay970
Compensation210
Capital Structure191
Corporate Governance193
Other60
Shareholder Rights and Defenses31

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
BRIGHTSPRING HEALTH SERVICES, INC.May 21, 2026$53M50
MACOM TECHNOLOGY SOLUTIONS HOLDINGS, INCMarch 5, 2026$47M100
SANMINA CORPORATIONMarch 9, 2026$43M121
LATTICE SEMICONDUCTOR CORPORATIONMay 1, 2026$35M100
GLAUKOS CORPORATIONMay 28, 2026$35M40
BRIDGEBIO PHARMA, INC.June 22, 2026$31M70
GUARDANT HEALTH, INC.June 17, 2026$30M50
MKS, INC.May 11, 2026$29M81

Notable votes against management

MeetingCompanyProposalFundMgmt
March 9, 2026SANMINA CORPORATIONTo consider and vote upon the stockholder proposal entitled ''Independent Board Chairman,'' requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposalAgainstFor
May 11, 2026MKS, INC.A shareholder proposal to reduce the threshold percentage of shareholders required to call a special meeting of shareholders from 40% to 10%, if properly presented at the meeting. Shareholder proposalAgainstFor
May 14, 2026FLOWSERVE CORPORATIONShareholder Proposal requesting an annual advisory shareholder vote regarding Flowserve stock repurchases. Shareholder proposalAgainstFor
August 4, 2025EAGLE MATERIALS INC.Non-binding advisory stockholder proposal requesting the declassification of our Board of Directors. Shareholder proposalForAgainst
May 14, 2026WYNDHAM HOTELS & RESORTS, INC.To vote on a stockholder proposal, if properly presented at the meeting, regarding stockholder ability to act by written consent. Shareholder proposalAgainstFor

Search this fund’s votes by company

792 ballot items at 96 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, JNL/Invesco Small Cap Growth Fund voted at 96 shareholder meetings of 96 companies, on 792 ballot items in all. Where management made a recommendation, the fund followed it on 98.7% of the items and voted against it 5 times. Its most frequent area of disagreement was corporate governance (3 of its votes against management). It voted on 5 shareholder proposals. It voted FOR the board's own proposals more often than Jackson National's funds as a whole (95.0% against 92.4%). It voted differently from most Jackson National funds on 55 items.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Jackson National’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.